GroVida
Gro-Vida S.A. is a Portuguese medical cannabis cultivator operating a 20,000m² GACP and EU-GMP certified greenhouse in the Algarve, supplying pharmaceutical partners, clinics, and downstream patients across the UK, EU, and Australia.
- Company typePrivate
- Founded2019
- HeadquartersSão Brás De Alportel, Portugal
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What GroVida does
Gro-Vida S.A. is a privately held Portuguese medical cannabis cultivator founded in 2019 and headquartered in Luz de Tavira, Algarve. The company operates a 20,000m² high-technology hybrid greenhouse facility, leveraging the region's 300 days of annual sunshine to support year-round controlled-environment cultivation. It is licensed by INFARMED, I.P. for the cultivation, import and export of medical cannabis and holds GACP and EU-GMP certifications, positioning it as one of the first licensed cultivators in Portugal.
The company's core offering comprises three service lines: supply of GACP- and EU-GMP-certified medical cannabis flowers to pharmaceutical partners; toll growing services that allow clients to outsource cultivation while retaining control over their genetics; and logistics and distribution support through partners such as Rangel and NEWFLOW. Its genetic repository spans CBD-dominant to high-THC cultivars, enabling tailored product configurations for diverse therapeutic applications. Distribution is exclusively B2B, with disclosed enterprise offtake partners including Lyphe Clinic (UK clinic network) and Canopy Growth Germany GmbH (exclusive German market supply commencing H1 2025).
Gro-Vida serves pharmaceutical partners, medical cannabis clinics, and (downstream) patients across the United Kingdom, the European Union, and Australia. Revenue is generated through quote-based B2B supply contracts and service fees rather than disclosed pricing. The company is independently owned with no disclosed institutional investors, is led by Managing Director Mallory Bodnar, and had created over 30 new jobs in the twelve months following its INFARMED licensing. Its stated strategic intent is to become a world leader in production of the highest-quality medical cannabis through end-to-end supply chain solutions.
GroVida firmographics
Firmographics- Name
- GroVida
- Legal name
- Gro-Vida S.A.
- Website
- https://gro-vida.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Gro-Vida S.A. is a Portuguese medical cannabis cultivator operating a 20,000m² GACP and EU-GMP certified greenhouse in the Algarve, supplying pharmaceutical partners, clinics, and downstream patients across the UK, EU, and Australia.
- Ownership category
- akta.pro rank
Where GroVida is headquartered
LocationHeadquarters
- HQ city
- São Brás De Alportel
- HQ country
- Portugal
- HQ region
- Europe
Offices1 record
Markets served
GroVida business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Infrastructure, Personnel, Operations, Supply Chain, Marketing or Sales
Revenue model
- Medical Cannabis Supply: Supply of GACP-certified medical cannabis materials to pharmaceutical partners. The company cultivates and processes medical-grade cannabis flowers destined for international markets including the UK, European Union, and Australia.
- Toll Growing Services: Toll growing service allowing businesses to outsource cultivation to Gro-Vida's experienced team while maintaining control over their own genetics and product specifications. Provides cost-effective cultivation solutions for partners.
- Logistics and Distribution Services: Comprehensive logistics support including seamless transportation, storage, and distribution solutions facilitating efficient movement of cannabis products from cultivation to clients.
- Cultivation and Distribution License: Licensed by INFARMED, I.P. for cultivation, import and export of medical cannabis. Operates under GACP and EU-GMP certifications.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
GroVida product offering
Product offeringCore offering
Gro-Vida is a Portuguese-licensed cultivator that produces, processes, and supplies GACP and EU-GMP certified medical-grade cannabis flowers from its 20,000m² hybrid greenhouse facility in the Algarve region. Its commercial offerings comprise three service lines: (1) medical cannabis supply to pharmaceutical partners across the UK, EU, and Australia; (2) toll growing services that allow businesses to outsource cultivation while retaining control of their own genetics and specifications; and (3) integrated logistics and distribution support facilitating transportation, storage, and last-mile delivery.
Product overview
GroVida is a GACP-licensed medical cannabis cultivator operating a single integrated platform focused on cultivation services. The company offers three core service offerings: Medical Cannabis Supply (GACP-certified cannabis materials for pharmaceutical partners), Toll Growing Services (outsourced cultivation with client-controlled genetics), and Logistics Support (transportation, storage, and distribution). All services are delivered through the company's 20,000m² hybrid greenhouse facility in Portugal's Algarve region, which enables year-round cultivation. The company does not offer distinct branded products but rather service-based offerings across the medical cannabis supply chain.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Cannabis Supply Supply of GACP-certified medical cannabis materials tailored to clients' specific needs, providing pharmaceutical partners with high-quality cannabinoid-based medicines for therapeutic applications.
- Toll Growing Services Outsourced cultivation services allowing businesses to leverage Gro-Vida's experienced cultivation team at the 20,000m² Algarve greenhouse facility while maintaining control over their own genetics and product specifications.
- Logistics Support Comprehensive logistics services ensuring seamless transportation, storage, and distribution of cannabis products from Gro-Vida's Portuguese cultivation facility to pharmaceutical clients and clinic networks across international markets.
Quantifiable outcome
- Successfully exported to key global markets including UK, Germany, and Australia
- +2 more outcomes
Companies that use GroVida
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
GroVida technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
GroVida partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered flagship, core and minor.
- Canopy Growth Germany GmbHflagshipGro-Vida secured a supply agreement with Canopy Growth Germany GmbH, a subsidiary of Canopy Growth Corporation. Under the terms, Gro-Vida will supply EU-produced GMP-certified medicinal cannabis flower for exclusive sale in Germany's rapidly growing medicinal cannabis market, with supply commencing in the first half of 2025. This partnership is part of Canopy Growth's global strategy for diverse, high-quality supply chain.
- Lyphe CliniccoreStrategic partnership between Lyphe Clinic (UK-based medical cannabis clinic) and Gro-Vida to enhance medical cannabis access in the UK. The collaboration provides Lyphe Clinic patients with streamlined supply chain and consistent access to prescribed medication, with greater control over quality and cost of medical cannabis.
- OPCMminorOrganização Portuguesa de Cannabis Medicinal (Portuguese Medical Cannabis Organization) - association partner shown in logos section.
- PortocannaminorPortuguese cannabis company - partner shown in logos section.
- CanapacminorPortuguese cannabis company - partner shown in logos section.
- RangelminorLogistics and distribution partner shown in logos section.
- NEWFLOWminorLogistics partner shown in logos section.
- LEFminorPartner shown in logos section.
Scale indicators8 records
Recent moves5 records
Expansion highlights6 records
GroVida competitors and assessment
Company assessmentDirect peers
- Little Green Pharma: Australian-based medical cannabis cultivator with EU-GMP certification exporting to European markets. Comparable to Gro-Vida in being a smaller, internationally focused cultivator targeting regulated medical cannabis markets in Europe and beyond.
- Clever Leaves: Clever Leaves is a multi-country medical cannabis cultivator with EU-GMP certification producing flower for European and international markets. Like Gro-Vida, it operates as a wholesale B2B supplier to pharmaceutical partners rather than running retail dispensaries.
- RPK Biopharma: Portuguese medical cannabis cultivator operating under INFARMED licensing in Portugal. Comparable to Gro-Vida as a domestic Portuguese peer competing for the same EU-GMP certified medical cannabis export opportunity.
- Khiron Life Sciences: International medical cannabis company with cultivation operations and EU distribution. Comparable to Gro-Vida in its B2B supply of EU-GMP certified medical cannabis flower to European markets and clinic networks.
Emerging players
- Cantourage: German medical cannabis distribution platform that imports EU-GMP flower from international cultivators and supplies German pharmacies. Comparable to Gro-Vida as a counterpart in the German medical cannabis supply chain, though operating on the distribution side.
- Sanity Group: German-headquartered European cannabis company with medical cannabis cultivation and distribution operations. Comparable to Gro-Vida as a peer in the European medical cannabis supply chain targeting the German market.
- Demecan: German medical cannabis cultivator focused on domestic German production and supply. Comparable to Gro-Vida as a European-based EU-GMP cultivator competing for German market share, though operating in the destination rather than export market.
Broad incumbents
- Canopy Growth Corporation: Canadian-headquartered global cannabis leader whose German subsidiary is Gro-Vida's flagship supply partner. Comparable as a broad incumbent in medical cannabis with EU GMP operations, and the counterparty in Gro-Vida's largest commercial agreement.
- Aurora Cannabis: Large Canadian cannabis producer with EU-GMP certified operations and European medical cannabis distribution. Comparable to Gro-Vida as a broad incumbent cultivator competing in European medical cannabis supply.
- Tilray Brands: Global cannabis leader with significant EU-GMP cultivation operations including Portugal-based facilities. Comparable to Gro-Vida as a competitor in EU-GMP medical cannabis production for European markets, but with much broader scale and product portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
GroVida social profiles
Digital presenceGroVida compliance and trust
Trust signalCompliance2 records
GroVida financial estimates
Financial estimateRevenue estimate
Valuation estimate
GroVida leadership team
Management profileNumber of profiles
Profiles1 record
GroVida funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GroVida M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GroVida
What does GroVida do?
Gro-Vida is a Portuguese-licensed cultivator that produces, processes, and supplies GACP and EU-GMP certified medical-grade cannabis flowers from its 20,000m² hybrid greenhouse facility in the Algarve region. Its commercial offerings comprise three service lines: (1) medical cannabis supply to pharmaceutical partners across the UK, EU, and Australia; (2) toll growing services that allow businesses to outsource cultivation while retaining control of their own genetics and specifications; and (3) integrated logistics and distribution support facilitating transportation, storage, and last-mile delivery.
Is GroVida a public or private company?
GroVida is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was GroVida founded?
GroVida was founded in 2019. It employs 11 to 50 people.
Where is GroVida based?
GroVida is headquartered in São Brás De Alportel, Portugal, in the Europe region.
How does GroVida make money?
Four revenue lines are on record. Medical Cannabis Supply is the primary driver. The others are toll Growing Services, logistics and Distribution Services and cultivation and Distribution License.
Who are GroVida's main competitors?
Direct peers on record are Little Green Pharma, Clever Leaves, RPK Biopharma and Khiron Life Sciences. Emerging players are Cantourage, Sanity Group and Demecan. Broad incumbents are Canopy Growth Corporation, Aurora Cannabis and Tilray Brands.
Does GroVida have an API?
No public API is recorded for GroVida.